Previous reports from this and other laboratories have shown that temperature-sensitive (ts) mutants, some of which contain altered M (membrane) or P (polymerase) proteins as well as protease activation mutants could be isolated from HVJ persistently infected cell lines demonstrating the selective advantage of these ts mutants in vitro over the original wild-type virus (Yoshida et al., 1979; Kimura et al., 1979; Ogura et al., 1981 Ogura et al., , 1982 Sato et al., 1981) . Holland and co-workers, using vesicular stomatitis virus (VSV) have shown that genome changes can accumulate during persistent infection (Holland et al., 1979) . Ter Meulen and coworkers have also demonstrated the occurrence of antigenic changes detectable by monoclonal antibodies within the H polypeptide of subacute sclerosing panencephalitis (SSPE) virus during the course of a non-productive, persistent infection in vitro (ter Meulen et al., 1981) . Monoclonal antibodies are highly specific reagents capable of detecting a single amino acid change in a determinant, and have been used to detect neutralization-resistant antigenic variants of HVJ, VSV and influenza A viruses spontaneously occurring at a frequency of approximately 10-s (Yewdell et al., 1979; Laver et al., 1979; Partner et al., 1980) . Monoclonal antibodies against HVJ glycoproteins have recently been described by several groups (Yewdell & Gerhard, 1982; Partner, 1981; Orvell & Grandien, 1982) .
In the present study, we have used three monoclonal antibodies which recognize antigenic determinants that are operationally non-overlapping and have higher neutralizing capability, to estimate the frequency of variation in the antigenic determinants of the haemagglutinin (HN) molecule of HVJ during persistent infection in vitro.
Hybridoma cell lines were produced by the methods of Gerhard et al. (1980) . Cell lines secreting virus=specific antibodies were identified by indirect immunofluorescence staining with fluorescein-conjugated anti-mouse IgG (Miles Laboratories) on acetone-fixed HVJinfected LLCMK2 cells in a micro-slide culture chamber (Bellco Glass, Inc). Antibodysecreting hybrids were cloned and grown in the peritoneal cavity of BALB/c mice to produce ascites. Monoclonal hybridoma antibodies were initially screened for neutralizing activity 0022-1317/84/0000-5847 $02.00 © 1984 SGM (1/20 dilution) (Fujizoki Corp., Japan) or PBS was added and incubated for a further 30 min, and then 50 ~tl of 0.5% chicken erythrocytes was added. Maximum agglutination titres were reached after 1 h at 4 °C. Titres are expressed as the reciprocal of the highest twofold dilution causing complete inhibition of haemagglutination by 8 HA units of virus.
t NT tests were done by incubating HVJ with an infectivity titre of 100 p.f.u, with twofold serial dilutions of monoclonal antibodies at 4 °C for 2 h and a further 1 h in the presence or absence of anti-mouse IgG serum (2 ~tl).
The remaining infectivities of the mixtures were assayed on LLCMK2 cells as described previously (Ogura et al., 1981) .
against plaque-purified wild-type HVJ. After several cell fusion experiments, three out of 34 hybridoma cell cultures secreting antibodies against HVJ HN protein were selected which could neutralize a large amount of virus completely apart from residual neutralization-resistant antigenic variants. Antibody specificity was determined by radioimmunoprecipitation of [35S]methionine-labelled virus particles and SDS-polyacrylamide gel electrophoresis (Laemmli, 1970) . These three hybridoma antibodies precipitated only a single polypeptide with the expected mol. wt. of the HN (data not shown).
The results of haemagglutination inhibition (HI) and neutralization (NT) tests using these monoclonal antibodies are shown in Table 1 . The monoclonal antibodies A7, B3 and Fll effectively inhibited viral haemagglutinating activity and infectivity. The subsequent addition of anti-mouse IgG serum enhanced HI or NT titres of antibodies B3 and F 11 by two-to fourfold. The NT activity of these clones almost exceeded their HI activity.
The frequency of neutralization-resistant antigenic variants present in cloned HVJ wild-type was determined by comparison of the titre of virus treated with monoclonal antibody to the titre of untreated virus (5 x 106 p.f.u.). As shown in Table 2 , the frequency of non-neutralized virus detected by antibody A7 was not greatly different at 5-to 25-, and at 5-to 125-fold dilution in the absence and presence of anti-mouse IgG serum, respectively. The monoclonal antibody B3 neutralized effectively at 5-fold, and at 5-to 125-fold dilution in the absence and presence of anti-mouse IgG serum, respectively. Antibody F11 showed effective activity at fivefold dilution, with or without anti-mouse IgG serum. When non-neutralized viruses were examined by NT, HI and immunofluorescent staining tests, all the viruses isolated at the frequencies of less than 10-4.7 were resistant to neutralization by the antibody used to isolate them but neutralized by the other antibodies; this suggests that antigenic determinants recognized by these three monoclonal antibodies were operationally non-overlapping. However, no variant viruses of this type were found among the viruses isolated at a frequency above 10-3.7. These data indicate that the frequency of neutralization-resistant antigenic variants in the wild-type stock virus was 10 -4.7 to 10 -5.2 irrespective of which of the monoclonal antibodies was employed.
Using these monoclonal antibodies, neutralization-resistant antigenic variants were isolated from HVJ-carrying cells. Four carrier cultures, GM2 (from a 3-methylcholanthrene-induced fibrosarcoma of an inbred golden hamster)-HVJ, LLCMK2-HVJ, Vero-HVJ and GEsl (from the embryo of an inbred golden hamster)-HVJ cells were recently established after infecting with wild-type HVJ purified by plaque isolation at 39 °C and maintained at 34 °C (Ogura et al., 1981) . Almost all of these carrier cells exhibited virus antigens, as judged by immunofluorescence. The result of isolation of neutralization-resistant antigenic variants from culture fluids of four HVJ-carrier cell lines at various passage stages are shown in Table 3 . The frequencies of antigenic variants detected in these four carrier cells by monoclonal antibodies were not very different. A total of 59, 21 and 30 clones of variants were isolated from 1.3 x 105 p.f.u, of virus • 10 3.7
Fll 5 10 -4.8 10 -4.8 25 > ]0 -3.7 > 10 -3.7 * Neutralization-resistant antigenic variants were isolated from HVJ wild-type stock which had been purified through plaque isolation at 39 °C and grown in the egg allantoic cavity. Fivefold serial dilutions of monoclonal antibodies (20 ktl) were mixed with 80 pl of HVJ with an infectivity titre of 5 × 106 p.f.u. After incubating the mixture for 16 h at 4 °C, 2 ~tl of anti-mouse IgG serum or Eagle's minimum essential medium was added and the mixture incubated further for 2 h at 4 °C. The infectivities of the mixtures were assayed on LLCMK2 cells as described previously (Ogura et al., 1981) . 10 -3.3 10 -3.8 10 -3.s * Confluent monolayers of each carrier culture were maintained in MEM without calf serum at 34 °C for 24 h and culture fluids were harvested for the isolation of variant viruses. Viruses in the culture fluids were activated by incubating with 1 ~tg/ml of N-acetyl trypsin (Sigma) for 10min at room temperature and then phenylmethylsulphonyl fluoride (10 ~tg/ml; Sigma) was added to stop the trypsin action. An aliquot of 50 pl of monoclonal antibody was added to 0-2 ml of culture fluid pretreated with trypsin and incubated for 16 h at 4 °C. Non-neutralized virus was titrated on LLCMK2 cells after further incubation with anti-mouse IgG sera for 2 h. t ND, Not detected.
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from HVJ-carrier cultures by selection with monoclonal antibodies A7, B3 and Fll. The frequencies calculated from the above data were 10 -3"3, 10 -3.8 and 10 -3"5, respectively. LLCMK2-HVJ cells at passage 20 produced about half the antigenic variants obtained in the present experiments. Antigenic variants selected from the culture fluid of LLCMK2-HVJ at passage 20 with antibodies A7, B3 and F11 occurred with a frequency of 10-3-4, 10-3.7 and 10-3.9, respectively. Every isolated virus clone was examined by neutralization, haemagglutination inhibition and immunofluorescent staining tests. No neutralization was observed with the monoclonal antibodies used for selection, whereas positive neutralization was observed with other antibodies (data not shown). The above frequencies were considerably higher than the frequencies of 10 -4.7 to 10 -5.2 detected in a stock preparation of HVJ wild-type. The frequencies of antigenic variants detected with monoclonal antibodies directed towards the haemagglutinin of HVJ or influenza A virus and the surface glycoprotein of VSV were of approximately the same order, namely 10-5 for the three different viruses (Yewdell et al., 1979; Laver et al., 1979; Portner et al., 1980) . Ter Meulen and co-workers reported that SSPE virus carrier cells became non-reactive with four out of six monoclonal antibodies against the H polypeptide of SSPE virus when tested by fluorescent antibody staining during the course of a non-productive, persistent infection in vitro (ter Meulen et al., 1981) . However, they established SSPE virus persistent infection initially by intracerebral inoculation of hamsters with virus and then Veto cells were infected by co-cultivation with brain tissue from these animals. So, in their experiments, there is a possibility that spontaneously occurring mutant viruses were selected by the immune system. Schild et al. (1983) demonstrated host-cell selection of influenza virus antigenic variants. In our HVJ persistently infected cell lines, the appearance of antigenic variants was rather random and, as is shown in Table 3 , accumulation of antigenic changes was not observed. These results suggest that variations in these antigenic determinants did not lead to selective advantage of viruses during persistent infection in vitro. It is still unclear how and why genome changes or mutations leading to variations in antigenicity, cytopathogenicity, temperature sensitivity and so on, some of which might seem to be advantageous, arise at higher frequencies during persistent infection in vitro. Youngner et al., using VSV, reported that treatment of host cells with actinomycin D enhanced the frequency of occurrence of ts mutants, suggesting that a host cell factor(s) involved in the fidelity of RNA transcription might be repressed by the antibiotic, permitting many errors to be made (Youngner et al., 1981) . In our preliminary experiments, attempts to enhance the frequency of antigenic variation by actinomycin D treatment and u.v.-irradiation of host cells were not successful. However, monoclonal antibodies are highly specific reagents capable of detecting a single amino acid change in a determinant (Laver et al., 1979) and their use may be a useful technique to elucidate the host cell factor(s) involved in virus variation during persistent infection in vitro.
